Search Results

Containing any of the words

Only of the type

Effectiveness and Safety of Stop Nosebleeds Device in Patients with Epistaxis Clinical Trial

Multicenter, open-label, study to evaluate safety,tolerability, pharmacokinetics and, pharmacodynamics of LCZ696 followed by a 52-week randomized, double-blind, parallel group, active-controlled study to evaluate the efficacy and safety of LCZ696 compared with enalapril in pediatric patients from1 month to < 18 years of age with heart failure due to systemic left ventricle systolic dysfunction) Drug Clinical Trial

Effect of interleukin-6 receptor inhibition with Tocilizumab in patients with rheumatoid arthritis Awareness Article

A Phase 3, Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination with Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer. Drug Clinical Trial

AN OPEN-LABEL STUDY IN PEDIATRIC (<18 YEARS OF AGE), SEVERE HEMOPHILIA A PARTICIPANTS (COAGULATION FACTOR ACTIVITY <1%) WITH OR WITHOUT INHIBITORS OR MODERATELY SEVERE TO SEVERE HEMOPHILIA B PARTICIPANTS (COAGULATION FACTOR ACTIVITY ≤2%) WITH OR WITHOUT INHIBITORS COMPARING 12 MONTHS OF HISTORICAL STANDARD TREATMENT TO MARSTACIMAB PROPHYLAXIS Drug Clinical Trial

SFDA Grants Orphan Drug Designation to “Gomekli” for the Treatment of Neurofibromatosis Type 1 (NF1) News

Assigning 750 Million to Develop Laboratories of Monitoring Imported Food News

SFDA Seized 47 Tons of Fruit-Flavored Tobacco Products Due to High Level of Glycerin News

The Saudi FDA Joins Global Regulators at 27th International Medical Device Regulators Forum (IMDRF) in Tokyo News

(SG-2007-249-H) Therapy Selector Switch may fail in HeartStart MRx MonitorDefibrillator Medical Report